← Evidence map

TrialCNS drugs2023

Efgartigimod Alfa in Generalised Myasthenia Gravis: A Profile of Its Use.

Young-A HeoPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

39 papers cite it

2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 37000339